review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Sharon Peacock | Q44172566 |
P2093 | author name string | Herbert P Schweizer | |
P2860 | cites work | Structural flexibility in the Burkholderia mallei genome | Q22066378 |
Melioidosis: epidemiology, pathophysiology, and management | Q24522461 | ||
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei | Q24550664 | ||
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei | Q24646881 | ||
Glanders in a military research microbiologist | Q28209215 | ||
Management of melioidosis | Q28245689 | ||
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei | Q28302368 | ||
Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline | Q33952994 | ||
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis | Q34077038 | ||
Oral fluoroquinolones for maintenance treatment of melioidosis | Q34456128 | ||
Variable presentation of neurological melioidosis in Northeast Thailand | Q39180747 | ||
Resistance to tellurite as a selection marker for genetic manipulations of Pseudomonas strains. | Q39562658 | ||
Construction of a broad host range cloning vector conferring triclosan resistance | Q40703196 | ||
Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. | Q42121617 | ||
Aminoglycoside and macrolide resistance in Burkholderia pseudomallei | Q42675337 | ||
A beta-lysine adenylating enzyme and a beta-lysine binding protein involved in poly beta-lysine chain assembly in nourseothricin synthesis in Streptomyces noursei | Q43849890 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Burkholderia mallei | Q134434 |
Burkholderia pseudomallei | Q140475 | ||
P304 | page(s) | 1689-1692 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Emerging Infectious Diseases | Q5235761 |
P1476 | title | Antimicrobial drug-selection markers for Burkholderia pseudomallei and B. mallei | |
P478 | volume | 14 |
Q33963058 | A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists |
Q64063395 | A novel selective medium for the isolation of Burkholderia mallei from equine specimens |
Q42005058 | Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization |
Q34499733 | Burkholderia thailandensis is virulent in Drosophila melanogaster |
Q37121962 | Complementation of Arginine Auxotrophy for Genetic Transformation of Coxiella burnetii by Use of a Defined Axenic Medium |
Q34523864 | Construction and characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agents, Bacillus anthracis, Yersinia pestis, Burkholderia mallei, and Burkholderia pseudomallei |
Q37410489 | Discovery of Inhibitors of Burkholderia pseudomallei Methionine Aminopeptidase with Antibacterial Activity |
Q37232449 | Engineering of tellurite-resistant genetic tools for single-copy chromosomal analysis of Burkholderia spp. and characterization of the Burkholderia thailandensis betBA operon |
Q36053090 | Epidemiology and investigation of melioidosis, Southern Arizona |
Q28253665 | Glyphosate resistance as a novel select-agent-compliant, non-antibiotic-selectable marker in chromosomal mutagenesis of the essential genes asd and dapB of Burkholderia pseudomallei |
Q34290270 | Stable, site-specific fluorescent tagging constructs optimized for burkholderia species |
Q39196701 | Versatile dual-technology system for markerless allele replacement in Burkholderia pseudomallei |
Search more.